The end of the trademark Dutch Design Duodopa Vest
In short, the trademark Dutch Design Duodopa Vest is no longer, if you have questions about a vest which you can use with your ambulatory infusion pump, use the contact form. You will be redirected to TeCuro.uk for this.
From what is understood from patients is that since 2018, AbbVie B.V. provides them with a shirt which has a hard box on the front to hold the duodopapump, it's called the Snug Vest, this is not the same as the Dutch Design
Duodopa Vest, which AbbVie B.V. stopped ordering since 2018. The Snug Vest is an extremely made bad copy of a very good product.
Since October 2013 there have been dealings with AbbVie B.V., located within the Netherlands for the manufacturing of the vest or shirts sold under the trademark Dutch Design Duodopa Vest.
This ended abruptly in November 2017 under not such friendly circumstances. As one can expect, a letter from the lawyer followed quickly on December 11th, 2017, followed by a application for declaration of invalidity for the trademark
Dutch Design Duodopa Vest, on April 28th, 2018, filed by AbbVie AB.
As AbbVie AB is located in Sweden and there never had been any dealings with them, it was somewhat of a surprise, it was expected that AbbVie B.V. from the Netherlands would take action. All arguments used by the Opponent are in reference to AbbVie B.V. so it is more or less the same.
On 7 Juli 2020, EUIPO - European Union Intellectual Property Office, came to the decision in favor of the opponent AbbVie AB. No surprise there, but what was surprising, the overall tone of the decision. It was decided not to appeal the decision, not really seeing the point in pursuing this matter any further.
You can find more information about the application for a declaration of invalidity under the link The Story
I want to thank all the patients for their support for the last 2 years. Unfortunately, the Dutch Design Duodopa Vest will not be sold any longer. It saddens me to say, that the AbbVie patients have to deal with the Snug Vest as good and as bad as they can.
Good that next to Duodopa is also LECIGON (TM), a proprietary treatment for advanced Parkinson’s disease. The levodopa, carbidopa and entacapone infusion therapy are inserted into the small intestine through a discreet, lightweight and wearable pump. If you have the option, choose wisely.